First human test for new stroke treatment
Disease control
Completed
This study tested the safety of an experimental drug called PP-007 in people who had just suffered a stroke caused by a blood clot. The 24 participants received two doses of the drug in addition to their standard stroke treatments, like clot-busting medication or removal. Researc…
Phase: PHASE1 • Sponsor: Prolong Pharmaceuticals • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC